In melanoma cells, mutations in the BRAF gene and anomalies in signaling pathways involving PI3K, AKT, and RAS favor the constitutive activity of NF-κB, resulting in enhanced proliferation and apoptosis resistance [205]. This evidence concerns the gene NFKB1 and melanoma.